Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

42.25USD
9 Dec 2016
Change (% chg)

$1.45 (+3.54%)
Prev Close
$40.81
Open
$41.29
Day's High
$43.58
Day's Low
$41.11
Volume
1,401,075
Avg. Vol
1,350,106
52-wk High
$101.81
52-wk Low
$31.38

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Bonney

57 2016 Independent Chairman of the Board

Barry Greene

52 2016 President

John Maraganore

53 2007 Chief Executive Officer, Director

David-Alexandre Gros

44 2016 Principal Financial Officer, Chief Business Officer, Senior Vice President

Yvonne Greenstreet

53 2016 Chief Operating Officer, Executive Vice President